5 Top Small-Cap Value Funds to Buy for Long-Term Growth

Why It Matters

Small‑cap value funds offer a compelling blend of discount pricing and outsized growth, providing diversification and higher return potential in a volatile market. Their strong recent performance signals a viable avenue for investors seeking to capture the rebound of under‑appreciated companies.

Key Takeaways

• Invesco VSCAX posted 25.6% 3‑yr return, 1.05% expense ratio.
• Goldman GSATX delivered 15.3% 3‑yr return, 1.20% expense ratio.
• Bridgeway BOSVX achieved 14.8% 3‑yr return with 0.47% fees.
• Nuveen NSCAX returned 14.7% over three years, 1.20% expense.
• Fidelity FCVAX posted 11.4% 3‑yr return, 1.20% expense ratio.

Pulse Analysis

The recent rally in U.S. stocks, buoyed by AI‑centric chipmakers and a cooling VIX, has reignited interest in segments that were previously undervalued. Small‑cap value equities sit at the intersection of low price‑to‑earnings multiples and high growth potential, making them attractive when broader market sentiment improves. As investors navigate lingering geopolitical risks and uneven economic data, funds that target discounted small‑cap stocks can provide a defensive buffer while still participating in upside from a recovering economy.

Value‑oriented small‑cap funds differentiate themselves through disciplined screening for companies trading below book value, offering higher dividend yields and tighter balance sheets. Their exposure to niche sectors—such as specialty finance, industrials and emerging tech—means they can capture earnings acceleration that larger, more mature firms may miss. Moreover, the expense ratios of the highlighted funds are competitive, with Bridgeway’s BOSVX standing out at just 0.47%, allowing more of the fund’s returns to flow to investors. The modest fees, combined with the funds’ consistent three‑year outperformance, reinforce the case for allocating a portion of a diversified portfolio to this space.

Among the five top‑ranked funds, Invesco’s VSCAX leads with a 25.6% three‑year annualized return, reflecting strong stock‑selection in sectors like technology and finance. Goldman’s GSATX and Bridgeway’s BOSVX also deliver double‑digit growth, while Nuveen’s NSCAX and Fidelity’s FCVAX provide solid performance with broader international exposure. For investors willing to accept higher volatility, these funds offer a pathway to capture the upside of companies poised for a post‑recession rebound, especially as interest‑rate stability and fiscal stimulus continue to support smaller enterprises. Selecting a mix of these funds can enhance sector diversification and improve the risk‑adjusted return profile of a long‑term investment strategy.